Comparison of Rosuvastatin and Atorvastatin in achieving the treatment goals of dyslipidemia at a tertiary centre

Abstract

Background: Dyslipidemia and atherosclerosis are closely related from the beginning to the end stages that lead to clinical events. The present study was conducted to compare Rosuvastatin (10 mg) and Atorvastatin (10 mg) in achieving the treatment goals of dyslipidemia.